Biotech Eiger Can Take Sentynl's Improved Drug Bid In Ch. 11
Eiger BioPharmaceuticals Inc. received approval Wednesday to select a $30 million base offer for its Zokinvy drug and use cash collateral after a Texas bankruptcy judge dismissed objections to the relief,...To view the full article, register now.
Already a subscriber? Click here to view full article